Sema3a as a Novel Therapeutic Option for High Glucose-Suppressed Osteogenic Differentiation in Diabetic Osteopathy
Conclusion: High glucose suppresses osteogenic differentiation in MC3T3 and sema3a may take part in this process. The application of exogenous sema3a alleviates high glucose-induced inhibition of osteoblast differentiation in diabetic osteopathy.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
More News: Diabetes | Diabetes Mellitus | Endocrinology | Orthopaedics | Osteoporosis | Pain | Study